Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03192371
Recruitment Status : Withdrawn (Due to supply constraints & prioritization according to medical need (availability of alternative rabies vaccines), Rabipur will no longer be supplied to China.)
First Posted : June 20, 2017
Last Update Posted : February 26, 2018
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : May 12, 2019
Estimated Study Completion Date : May 12, 2019